News

Filter

Current filters:

Biotechnology

226 to 235 of 96944 results

Proteostasis and Astellas link on up to $1.2 billion R&D deal

Proteostasis and Astellas link on up to $1.2 billion R&D deal

05-11-2014

Japanese drug major Astellas Pharma has entered into a collaboration with US drug developer Proteostasis…

Astellas PharmaNeurologicalOphthalmicsPharmaceuticalProteostasis TherapeuticsResearch

Regeneron third-qtr net profit plunges despite strong sales growth

Regeneron third-qtr net profit plunges despite strong sales growth

04-11-2014

US biotech firm Regeneron posted revenue of $725.8 million for the third quarter of 2014, a rise of 22%…

alirocumabBayerBiotechnologydupilumabEyleaFinancialOphthalmicsRegeneronResearchSanofisarilumab

Amgen’s trebananib disappoints in ovarian cancer trial

Amgen’s trebananib disappoints in ovarian cancer trial

04-11-2014

USA-based Amgen, the world’s largest independent biotech firm, revealed that a late-stage trial of…

AmgenBiotechnologyOncologyResearchtrebananib

Reckitt Benckiser appoints Cary Claiborne as chief financial officer

Reckitt Benckiser appoints Cary Claiborne as chief financial officer

04-11-2014

Global specialty pharma company Reckitt Benckiser has appointed Cary Claiborne as chief financial officer.

BoardroomCary ClaiborneChief financial officerPharmaceuticalReckitt Benckiser

New Phase IIIa data further demonstrate benefits of liraglutide in obesity

04-11-2014

Positive new data from the Phase IIIa SCALE Obesity and Prediabetes trial were presented today at Obesity…

DiabetesliraglutideMetabolicsNovo NordiskPharmaceuticalResearchSaxendaVictoza

Diabetes drugs could potentially reverse Alzheimer's damage, say UK researchers

Diabetes drugs could potentially reverse Alzheimer's damage, say UK researchers

04-11-2014

A new study has suggested that drugs currently being used to treat diabetes also have the potential to…

liraglutidelixisenatideNeurologicalNovo NordiskPharmaceuticalResearchSanofiUK

Dana-Farber Cancer Institute and Astellas in three-year collaboration on small molecule inhibitors

Dana-Farber Cancer Institute and Astellas in three-year collaboration on small molecule inhibitors

04-11-2014

Boston-based Dana-Farber Cancer Institute and Japanese drug major Astellas Pharma have entered into a…

AstellasOncologyPharmaceuticalResearchUSA

EGA and EBG see EMA latest biosimilars guidance as “important step forward”

EGA and EBG see EMA latest biosimilars guidance as “important step forward”

04-11-2014

The European Generic medicines Association (EGA) and the European Biosimilars Group (EBG), a sector group…

BiosimilarsEuropeGenericsRegulation

MedImmune to acquire company to strengthen focus on biomarkers in immuno-oncology

MedImmune to acquire company to strengthen focus on biomarkers in immuno-oncology

04-11-2014

MedImmune, a US subsidiary of Anglo-Swedish pharma major AstraZeneca has entered into an agreement to…

AstraZenecaDefiniensMedImmuneMergers & AcquisitionsOncologyPharmaceutical

226 to 235 of 96944 results

Parexel

Parexel

Back to top